A new cohort-based program aims to help adults with severe phone habits recover through structured group support, testing a novel approach in digital wellness.
Cohort-Based Digital Wellness: A New Path For Phone Recovery
Browsing Category
Healthcare operations
145 posts
Vanda Pharmaceuticals Announces Participation At September 2026 Investor Conferences
Vanda Pharmaceuticals announced its participation in multiple investor conferences scheduled for September 2026, highlighting upcoming engagement with investors.
Father-to-daughter Bone Marrow Transplant Gives Daughter A Second Chance At Life
A father successfully donates bone marrow to his daughter, providing her with a second chance at life. The procedure highlights advances in familial transplants.
Financial Stability Roadmap For Widowers: Weekly Insights
A new weekly household money map tool aims to help widowers and their families manage finances after loss, tested via pilot programs with estate attorneys.
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of LEQEMBI® (Lecanemab) For Early Alzheimer’s Disease
Canada’s drug agency has issued a final positive recommendation to support public reimbursement of Leqembi (lecanemab) for early Alzheimer’s disease, marking a significant policy shift.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces trial results showing notable progression-free survival benefits for ORPATHYS® combined with TAGRISSO® in lung cancer patients in China.
How The AI Leaderboard Evolves After The Demo Concludes
The AI leaderboard shifts as models demonstrate management capabilities in a live company simulation, highlighting strengths and gaps in AI decision-making.
The Impact Of New FDA-Approved Pancreatic Cancer Therapy On Consumer Trends
The FDA’s approval of a new targeted pancreatic cancer therapy is influencing consumer health trends and market responses, prompting shifts in awareness and demand.
Xenon To Highlight Phase 3 X-TOLE2 Clinical Data And Rational Polytherapy Potential For Azetukalner At EEC 2026
Xenon Pharmaceuticals will showcase Phase 3 X-TOLE2 clinical trial results and discuss rational polytherapy potential for Azetukalner at EEC 2026.
Is The Brain About To Take Center Stage In Consumer Health Signals?
Emerging developments suggest the brain may soon become a key focus in consumer health safety monitoring, with early signals pointing to a shift in industry attention.
